NASDAQ:SAGE   Sage Therapeutics, Inc.
SAGE - RSI close to overbought 70 but Ichimoku shows a nice uptrend even from here. Without market disruption from commodity futures or forex or bond perspective, SAGE should go well along with the sector IBB && XBI.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.